No Data
No Data
Argent BioPharma Enters Germany - Europe's Largest Market
Argent BioPharma Amends Convertible Note Terms With US-Based Search Fund; Shares Fall 6%
Argent BioPharma Transfers Malta, Slovenia Production Sites to Third-Party Operators
Argent BioPharma Streamlines Operations and Advances Neuroimmune Therapies
Argent BioPharma to Collaborate With AusCann on Cannabinoid-Based Pharmaceutical Development
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.